Event

BioCryst Pharmaceuticals Inc (BCRX)

BioCryst Pharmaceuticals Inc (BCRX) Files Form 10-Q for Period Ending 2022-08-05

Business News

Tonix Pharmaceuticals Holding Corp (TNXP)

Tonix Pharmaceuticals Announces First Patient Dosed in the Investigator-Initiated FOCUS Study of Tonix’s Intranasal Potentiated Oxytocin in AVP-D Conducted by …

SEC News

GSK plc (GLAXF)

New Form 6-K - GSK plc Filed: 2025-10-22 AccNo: 0001654954-25-012042 Size: 1 MB


Company Report

MAIA Biotechnology Inc. (MAIA)

Understanding Clinical Trials - Part 1 of 2

FDA Approval

ALEMBIC

FDA approve TRIAMCINOLONE ACETONIDE

About Us

The main activity of our team is the prompt receipt of open information from various sources in order to analyze the market reaction to this information.

Our strategies:

  • a combination of various open sources of information with the identification and use of those that provide information most quickly;
  • extracting information mainly by automatic means using artificial intelligence;
  • providing users with structured information with modern available development tools;
  • the use of approaches and tools of machine learning methods to identify the most important events that affect the market;